Pharmacological properties of -mangostin, a novel histamine H 1 receptor antagonist

By Chairungsrilerd N.   Furukawa K.-I.   Ohta T.   Nozoe S.   Ohizumi Y.  

European Journal of Pharmacology, Vol. 314, Iss. 3, 1996-10 ,pp. : 351-356

Elsevier

Access to resources Recommend Favorite

Preclinical Pharmacology of Bilastine, a New Selective Histamine H1 Receptor Antagonist: Receptor Selectivity and in Vitro Antihistaminic Activity

By Corcóstegui Reyes   Labeaga Luis   Innerárity Ana   Berisa Agustin   Orjales Aurelio  

Drugs in R&D, Vol. 6, Iss. 6, 2005-01 ,pp. : 371-384

Adis International

Access to resources Recommend Favorite

(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions

By Jin G.-Z.   Zhu Z.-T.   Fu Y.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 4-7

Elsevier

Access to resources Recommend Favorite

Characterisation of the specific binding of the histamine H 3 receptor antagonist radioligand [ 3 H]GR168320

By Brown J.D.   O'Shaughnessy C.T.   Kilpatrick G.J.   Scopes D.I.C.   Beswick P.   Clitherow J.W.   Barnes J.C.  

European Journal of Pharmacology, Vol. 311, Iss. 2, 1996-09 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite

Therapeutic potential of histamine H 3 receptor agonists and antagonists

By Leurs R.   Blandina P.   Tedford C.   Timmerman H.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 5, 1998-05 ,pp. : 177-184

Elsevier

Access to resources Recommend Favorite